Strategic application of CuAAC click chemistry in the modification of natural products for anticancer activity DOI Creative Commons

Zaozao Xiao,

Yuang Gu,

Hewei Dong

et al.

European Journal of Medicinal Chemistry Reports, Journal Year: 2023, Volume and Issue: 9, P. 100113 - 100113

Published: Sept. 7, 2023

Natural products play a key role in the history of human drug discovery, and especially for anticancer agents. Copper(I)-catalyzed alkyne-azide [3+2] cycloaddition (CuAAC) reaction is perhaps most powerful method efficient modification complex natural products, enabling direct incorporation various functional groups accompanied by formation multifunctional 1,2,3-triazole motif, which could not only serve as an basic hydrophilic connecting group but also bioisosteres 5- or 6-membered heterocycles amide group, thus facilitating improvement activities and/or drug-like properties. This contribution extensively summarizes state-of-the-art application activity. The aim to gain deep understanding fruitful achievements well limitations CuAAC click chemistry product activity, provide perspectives directions regarding future studies medicinal chemistry.

Language: Английский

An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities DOI Creative Commons
Shah Alam Khan,

Mohammad Jawaid Akhtar,

Urvashee Gogoi

et al.

Pharmaceuticals, Journal Year: 2023, Volume and Issue: 16(2), P. 179 - 179

Published: Jan. 24, 2023

Acetylcholine (ACh) neurotransmitter of the cholinergic system in brain is involved learning, memory, stress responses, and cognitive functioning. It hydrolyzed into choline acetic acid by two key cholinesterase enzymes, viz., acetylcholinesterase (AChE) butyrylcholinesterase (BuChE). A loss or degeneration neurons that leads to a reduction ACh levels considered significant contributing factor development neurodegenerative diseases (NDs) such as Alzheimer’s disease (AD). Numerous studies have shown inhibitors can raise level and, therefore, enhance people’s quality life, at very least, it temporarily lessen symptoms NDs. 1,2,3-triazole, five-membered heterocyclic ring, privileged moiety, is, central scaffold, capable interacting with variety receptors enzymes exhibit broad range important biological activities. Recently, has been clubbed other pharmacophoric fragments/molecules hope obtaining potent selective AChE and/or BuChE inhibitors. The present updated review succinctly summarizes different synthetic strategies used synthesize 1,2,3-triazole moiety. also highlights anticholinesterase potential various di/trihybrids reported past seven years (2015–2022), including rationale for hybridization an emphasis on their structural features optimization treat

Language: Английский

Citations

55

1,2,3-triazole and chiral Schiff base hybrids as potential anticancer agents: DFT, molecular docking and ADME studies DOI Creative Commons
Yonas Belay, Alfred Muller,

Fanikie S. Mokoena

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: March 23, 2024

Abstract A series of novel 1,2,3-triazole and chiral Schiff base hybrids 2 – 6 were synthesized by condensation reaction from pre-prepared parent component the (1,2,3-triazole 1) primary amines their chemical structure confirmed using NMR FTIR spectroscopies, CHN elemental analysis. Compounds 1 evaluated for anticancer activity against two cancer PC3 (prostate) A375 (skin) MRC-5 (healthy) cell lines Almar Blue assay method. The compounds exhibited significant cytotoxicity tested lines. Among 3 showed very good inhibition low toxicity healthy All high binding affinity Androgen receptor modulators (PDB ID: 5t8e) Human MIA 1i1j) inhibitors compared to reference drug (cisplatin). Structure relationships (SARs) is in agreement with DFT molecular docking studies. desirable physicochemical properties likeness.

Language: Английский

Citations

25

1,2,3-Triazole-Containing Compounds as Anti–Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure–Activity Relationship DOI Creative Commons
Ting Liang,

Xiangyang Sun,

Wenhong Li

et al.

Frontiers in Pharmacology, Journal Year: 2021, Volume and Issue: 12

Published: June 11, 2021

Lung cancer is the most common malignancy and leads to around one-quarter of all deaths. Great advances have been achieved in treatment lung with novel anticancer agents improved technology. However, morbidity mortality rates remain extremely high, calling for an urgent need develop anti-lung agents. 1,2,3-Triazole could be readily interact diverse enzymes receptors organisms through weak interaction. can not only acted as a linker tether different pharmacophores but also serve pharmacophore. This review aims summarize recent 1,2,3-triazole-containing compounds potential, their structure-activity relationship (SAR) together mechanisms action discussed pave way further rational development candidates.

Language: Английский

Citations

95

Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus DOI
Yujie Gao, Yuan Chen, Yubin Cao

et al.

European Journal of Medicinal Chemistry, Journal Year: 2020, Volume and Issue: 213, P. 113056 - 113056

Published: Nov. 30, 2020

Language: Английский

Citations

85

The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool DOI
Deniz Lengerli, Kübra İbiş, Yahya Nural

et al.

Expert Opinion on Drug Discovery, Journal Year: 2022, Volume and Issue: 17(11), P. 1209 - 1236

Published: Sept. 27, 2022

The 1,2,3-triazole ring occupies an important space in medicinal chemistry due to its unique structural properties, synthetic versatility and pharmacological potential making it a critical scaffold. Since is readily available through click for creating compound collections against various diseases, has become emerging area of interest chemists.This review article addresses the properties the1,2,3-triazole nucleus as intriguing system drug discovery while focusing on most recent strategies exploited design development analogs inhibitors biological targets.Evidently, with features enormous diseases pharmacophore, bioisoster or platform. evidence indicates that may be more molecules near future along increasing understanding prominent roles structures. feasibility triazole make certainly ideal libraries constructive structure-activity relationship studies. However, comparative target-specific studies are needed gain deeper molecular recognition.[Figure: see text].

Language: Английский

Citations

59

Anti-melanogenesis and anti-tyrosinase properties of aryl-substituted acetamides of phenoxy methyl triazole conjugated with thiosemicarbazide: Design, synthesis and biological evaluations DOI

Hona Hosseinpoor,

Sara Moghadam Farid,

Aida Iraji

et al.

Bioorganic Chemistry, Journal Year: 2021, Volume and Issue: 114, P. 104979 - 104979

Published: May 11, 2021

Language: Английский

Citations

47

1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens DOI

Cui Deng,

Heng Yan,

Jun Wang

et al.

European Journal of Medicinal Chemistry, Journal Year: 2022, Volume and Issue: 244, P. 114888 - 114888

Published: Oct. 29, 2022

Language: Английский

Citations

39

Synthesis and biological evaluation of novel [1,2,3]triazolo-pyrrolo[1,2-a]pyrido[4,3-d]pyrimidines as EGFR targeting anticancer agents DOI

Sandhya Rani Bandi,

Natte Kavitha, Satheesh Kumar Nukala

et al.

Journal of Molecular Structure, Journal Year: 2022, Volume and Issue: 1274, P. 134378 - 134378

Published: Oct. 20, 2022

Language: Английский

Citations

32

Ramachary-Bressy-Wang [3+2]cycloaddition reaction: Synthesis of fully decorated 1,2,3-triazoles as potent anticancer and EGFR inhibitors DOI

Manoj Kumar N,

Satheesh Kumar Nukala,

Narasimha Swamy Thirukovela

et al.

Journal of Molecular Structure, Journal Year: 2022, Volume and Issue: 1262, P. 132975 - 132975

Published: April 3, 2022

Language: Английский

Citations

31

Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens DOI
Jingyue Gao,

Haodong Hou,

Feng Gao

et al.

European Journal of Medicinal Chemistry, Journal Year: 2022, Volume and Issue: 247, P. 115026 - 115026

Published: Dec. 21, 2022

Language: Английский

Citations

31